📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Salivary Gland Infection Market Analysis

ID: MRFR//2506-HCR | 76 Pages | Author: Kinjoll Dey| June 2024

Salivary gland infection market dynamics are complex and influenced by multiple factors that determine occurrence of the disease, diagnose and treatment. Frequently, salivary gland inflammation and swelling results from bacterial or viral infections. Increasing global prevalence is the principal driver of salivary gland infection treatment market growth. Poor oral hygiene, dehydration, and a greater incidence of viral infections contribute to this increase.

Market dynamics are largely shaped by the diagnostic landscape. Diagnostic techniques for salivary gland infections have continued to evolve as healthcare providers seek early detection and quick intervention. Advanced imaging technologies such as ultrasound and sialography have taken over the market leading to increased accuracy in diagnosis at an appropriate time. This is attributed to the need for specific facts on which proper treatments can be based.

Market dynamics include a number of treatment options for salivary gland infections. For instance, antibiotics may be prescribed in case of bacterial infection whereas antiviral medications may be necessary for treating viral infection. Sometimes patients require surgical interventions when they encounter severe cases such as removal of obstructions or drainage of abscesses. The product range includes various pharmaceuticals used for distinct purposes in salivary glands’ infection therapy while their rivalry shapes up general tendencies within this sphere.

Moreover, regulatory environment greatly shapes market dynamics in terms of drug approval and commercialization regarding agents associated with saliva ducts inflammations (Saluja et al., 2008). This has resulted in strict regulations aimed at ensuring safety, efficacy as well as development and introduction into the market new products (Mabar et al., 2015). In order to maintain patient safety and reach better outcomes regulatory bodies demand highest quality standards hence companies operating within this sector must comply with them thereby enhancing stability and predictability across these spaces.

On another note, economic landscape and healthcare infrastructure variations across different regions also influence the market dynamics of salivary gland infections (Grolleman et al., 2015). This is because there is a high level of diagnosis in developed economies with well-established health care systems and access to state-of-the-art treatments (Grolleman et al., 2015). Conversely, developing regions experience low rates of awareness and accessibility as well as affordability of diagnostics and therapeutic options. This also contributes to altering market dynamics due to different healthcare disparities and various economic conditions between such areas.

Furthermore, technological advancements together with research activities also impact on the market dynamics of salivary gland infections (Bhattacharya et al., 2018). Researchers are still putting an effort to identify new therapeutic targets for these diseases, diagnostic biomarkers and innovative treatment methods (Bhattacharya et al., 2015). The emergence of breakthroughs in research could potentially change the face of this market by bringing about more effective interventions that are specifically targeted at certain cohorts. These moves are pushed by academic collaboration with industry players alongside relevant healthcare institutions in fostering product innovation which will eventually influence the growth trajectory of this sector.

Salivary Gland Infection Market Overview

Market synopsis of salivary gland infection marketThe salivary gland infection Market is expected to reach USD 12.12 Billion by 2032 at a CAGR 9.1% during the forecast period 2024-2032.

Salivary Gland Infection Market

Salivary gland infection is one of the most common medical condition across the globe. These infections are mostly caused due to bacteria or viruses. Salivary gland infection affects salivary duct or gland.

Increasing prevalence of various salivary gland infections, changing disease patterns, and environmental changes are major drivers for the market growth. Rising funding for R&D and clinical trials are leading to improved product development is another key factor for market growth. Improved hygiene practices, growing awareness about self-care and advanced diagnosis and treatment options are important driving forces for the market.

November of 2022, however, witnessed Alembic Pharmaceuticals Ltd disclosing that generic Glycopyrrolate injection is now going to get approval from US health regulators that can decrease saliva and mucus flow into the airways before surgery takes place. The FDA has indicated its support towards an Abbreviated New Drug Application (ANDA) for Glycopyrrolate Injection comprising of single-dose vials in different sizes such as 0.2 mg/1mL and 0.4mg/2 mL (0.2 mg/mL,) among others also consisting of another strength like 1mg/5 mL(0 .2mg/ml). Moreover, according to the company, adults could use Glycopyrrolate Injection as an edjunitive anticholinergic therapy when immediate influence on cholinergic receptors is needed beside or instead of oral preparations while dealing with peptic ulcers in adult patients.

Another prostate cancer treatment; ERLEADA hit the US in April 2023 all the way from Janssen Pharmaceutical Companies of Johnson & Johnson having a tablet strength of 240mg. An Androgen Receptor Inhibitor (ARI) branded Erleada has been approved for nmCRPC patients and mCSPC patients which means non-metastatic castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer respectively but this time with a stronger tablet to take; instead of needing four tablets per day before, now one tablet suffices to take their entire once-a-day dose

In August 2022, LordsMed formed an exclusive alliance with Sensing Self, a diagnostics kit manufacturer based in Singapore, to introduce one of India’s first-ever COVID-19 saliva-based rapid antigen test kits.

Eurobio Scientific reached an exclusive distribution agreement for the commercialization of OraQuick’s saliva self-test in France and her overseas territories with Orasure.

Study objectives of salivary gland infection market:

  • To provide detailed analysis of the salivary gland infection market structure with historical and forecast revenue for the next 6 years of the various segments and sub-segments.

  • To provide insights about the key drivers, restraints, opportunities and challenges affecting the growth of salivary gland infection market

  • To provide analysis of the market with respect to four main geographies and their countries – the Americas, Europe, Asia-Pacific, and Middle East & Africa.

  • To provide detailed analysis of the market segmented by diagnosis, treatment, end user, and its sub-segments.

  • To provide a detailed analysis of salivary gland infection market mainly based on Value Chain analysis, Porter’s Five Forces, Price analysis, and Supply Chain analysis etc.

  • To provide a detailed country level analysis of the market with respect to the current market size and future prospects.

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the salivary gland infection market

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the salivary gland infection market

Intended Audience:

  • Salivary gland infection drugs manufacturers

  • Salivary Gland Infection drugs and treatment providers

  • Hospitals and clinics

  • Medical Research laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors

Salivary Gland Infection Market Segment Insights

Salivary Gland Infection Diagnosis Insights

On the basis of diagnosis which comprises of Plain radiography, sialography, high-resolution ultrasonography, Computed tomography (CT), Magnetic Resonance Imaging (MRI), radionuclide scintigraphy, and others. Sialography is further sub-segmented into CT sialography (ultrafast technique), fluoroscopic/conventional sialography (with or without digital subtraction), and MR sialography.

Salivary Gland Infection Treatment Insights

On the basis of treatment, the market has been segmented into medication, surgery, aspiration, home care, and others. Medication is further sub-segmented into antibiotics and others. Antibiotics are further sub-segmented into dicloxacillin, cephalosporins, clindamycin, and others. Surgery includes removal of part of the parotid salivary gland, removal of all of the parotid salivary gland, removal of the submandibular salivary gland, and others. Home remedies include increased water intake, rest, refraining from smoking, massaging the gland with heat, and others.

Salivary Gland Infection End User Insights

On the basis of end user, it is segmented into hospitals & clinics, medical research centers, academic institutes, and others.

Salivary Gland Infection Regional Insights  

Considering the global scenario of the market, Americas holds the largest market share due to various factors such as increasing number of patients with various salivary gland infections and related disorders. European salivary gland infection market is the second largest where the west European countries are dominating the largest market share. Prevalence of various salivary gland infection is rising in Asia Pacific region. Additionally, increasing healthcare spending and rapidly changing healthcare sector, and government initiatives to improve public health are major growth drivers for Asia Pacific salivary gland infection market. Due to low knowledge of disease and treatments, low-income, and limited access to healthcare facilities, Middle East and Africa (ME&A) is likely to have a limited growth in the market.

Key Companies in the market of Salivary Gland Infection Market include

  • AbbVie Inc. (US)

  • Allergan (Republic of Ireland)

  • AstraZeneca (UK)

  • FUJIFILM Holdings Corporation (Japan)

  • General Electric Company (US)

  • GlaxoSmithKline plc. (UK)

  • Johnson & Johnson Services, Inc. (US)

  • Merck & Co., Inc. (US)

  • Pfizer Inc.(US)

  • Siemens Healthcare GmbH (Germany)

The report for Global Salivary Gland Infection Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.